Copenhagen - Delayed Quote • DKK
Novo Nordisk A/S (NOVO-B.CO)
At close: May 17 at 4:59 PM GMT+2
Major Holders
| Breakdown | |
|---|---|
| 6.06% | % of Shares Held by All Insider |
| 37.67% | % of Shares Held by Institutions |
| 40.10% | % of Float Held by Institutions |
| 1,182 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Boston Common Asset Management, LLC | 376.71k | Mar 31, 2024 | 0.01% | 340,283,041 |
| Gamma Investing LLC | 258 | Mar 31, 2024 | 0.00% | 233,051 |
| Atlas Capital Advisors LLC | 5.22k | Mar 31, 2024 | 0.00% | 4,713,419 |
| Zevin Asset Management, Inc. | 32.88k | Mar 31, 2024 | 0.00% | 29,700,503 |
| Pacer Advisors, Inc. | 116 | Mar 31, 2024 | 0.00% | 104,782 |
| Kennedy Capital Management, Inc. | 107.14k | Mar 31, 2024 | 0.00% | 96,780,463 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Europacific Growth Fund | 54.73M | Mar 31, 2024 | 1.61% | 49,440,082,470 |
| Vanguard International Stock Index-Total Intl Stock Indx | 42.77M | Jan 31, 2024 | 1.26% | 38,636,082,572 |
| New Perspective Fund Inc | 31.41M | Mar 31, 2024 | 0.93% | 28,370,568,703 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 25.48M | Dec 31, 2023 | 0.75% | 23,013,815,502 |
| Goldman Sachs GQG Partners International Opportunities Fund | 22.13M | Jan 31, 2024 | 0.65% | 19,990,510,188 |
| Fundamental Investors Inc | 19.68M | Mar 31, 2024 | 0.58% | 17,778,336,648 |
| iShares Core MSCI EAFE ETF | 18.98M | Mar 31, 2024 | 0.56% | 17,148,599,255 |
| Capital World Growth and Income Fund | 15.37M | Mar 31, 2024 | 0.45% | 13,887,253,618 |
| iShares MSCI Eafe ETF | 10.21M | Mar 31, 2024 | 0.30% | 9,226,934,772 |
| Growth Fund Of America Inc | 9.67M | Mar 31, 2024 | 0.29% | 8,730,989,656 |
Related Tickers
BAVA.CO Bavarian Nordic A/S
178.75
+3.12%
ZEAL.CO Zealand Pharma A/S
600.00
-2.99%
GMAB.CO Genmab A/S
2,041.00
+0.74%
ALK-B.CO ALK-Abelló A/S
152.00
-2.50%
GUBRA.CO Gubra A/S
302.00
+1.00%
VKTX Viking Therapeutics, Inc.
67.00
-2.98%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
1.4080
-0.98%
GMAB Genmab A/S
29.98
+1.11%
HNSA.ST Hansa Biopharma AB (publ)
36.50
-3.03%
ACIU AC Immune SA
3.1800
-6.74%